Results 191 to 200 of about 23,536 (264)

Effect of rapid antiretroviral therapy initiation on loss to follow-up, virologic failure, and immunologic failure among people living with HIV under the treat-all policy in China: a retrospective cohort study (2016-2023). [PDF]

Front Med (Lausanne)
Ao S, Zheng Y, Yang L, Nie Z, Li P, Long H.   +5 more
europepmc   +1 more source

High frequency of HIV-1 drug resistance among individuals with persistent low-level viremia during first-line antiretroviral therapy in Uganda. [PDF]

BMC Infect Dis
Sanyu G, Mayanja Y, Omooja J, Asio JN, Nannyonjo M, Ssemanda P, Hellen N, Ssewanyana I, Drago KC, Kaleebu P, Ssemwanga D.   +10 more
europepmc   +1 more source

Virologic, Lipid, Renal and Hepatic Laboratory Outcomes After Switching to Doravirine/Lamivudine/Tenofovir Disoproxil Fumarate in Treatment-Experienced People with HIV: Real-World Evidence from the SHINe-SHIC Cohort. [PDF]

Infect Dis Rep
Ceccarelli M, Venanzi Rullo E, Marino A, De Vito A, Micali C, Spampinato S, Russotto Y, Albanese A, Frasca MC, Sofia SA, Pellicanò GF, Celesia BM, Maggi P, Madeddu G, Nunnari G.   +14 more
europepmc   +1 more source

Mapping HIV-1 Genetic Diversity and Transmission Dynamics in Central African Children: Persistent Challenges and Molecular Complexity. [PDF]

Pathogens
Mounanga-Mourimarodi R, Falque G, Engone-Ondo JD, Oloumbou EF, Mouinga-Ondémé A.   +4 more
europepmc   +1 more source

Incident diabetes after switching to integrase strand transfer inhibitors in people with HIV in the USA and Canada: a cohort study. [PDF]

Lancet HIV
Hwang YJ, Lesko CR, Brown TT, Alexander GC, Althoff KN, Zalla LC, Pytell JD, Falade-Nwulia O, Tseng E, Moore RD, Marconi VC, Koethe JR, Silverberg MJ, Horberg MA, Lang R, Sterling TR, Fojo AT, North American AIDS Cohort Collaboration on Research and Design of the International Epidemiologic Databases to Evaluate AIDS.   +17 more
europepmc   +1 more source

Resistance Analysis of Weekly Islatravir Plus Lenacapavir in People With HIV at 48 Weeks. [PDF]

J Acquir Immune Defic Syndr
VanderVeen LA, Selzer L, Chang S, Li J, Diamond TL, Asante-Appiah E, Llamoso C, Rhee MS, Callebaut C.   +8 more
europepmc   +1 more source

Phylogenetic Evidence of Local HIV-1 Transmission and Antiretroviral Drug Resistance in the Middle East and North Africa. [PDF]

Viruses
Al-Fraihat E, Irshaid A, Sallam M, Snygg J, Awawdeh R, Al-Shakerchi H, Al-Baidhani S, Sallam M.   +7 more
europepmc   +1 more source

Virological and metabolic outcomes after switching to dolutegravir or rilpivirine in virologically suppressed adults with HIV in Thailand: an open-label, randomised, controlled, non-inferiority trial. [PDF]

Lancet Reg Health Southeast Asia
Kajeekul R, Ruenroengbun N, Wiwatrojanagul S, Kirdtongkum K, Chantaranothai W, Bin Khalid KE, Sirijatuphat R, Ngamprasertchai T.   +7 more
europepmc   +1 more source

Doravirine: A Return of the NNRTI Class?

Annals of Pharmacotherapy, 2019
Objective: To compare and contrast doravirine (DOR) with other agents in the nonnucleoside reverse transcriptase inhibitor (NNRTI) class, review safety and efficacy data from both completed and ongoing clinical trials, and outline the potential place in therapy of DOR. Data Sources: A literature search using the PubMed database (inception to June 2019)
Sarah R. Blevins, E. Kelly Hester, Daniel B. Chastain, David B. Cluck   +3 more
semanticscholar   +5 more sources